Nutex Health (NASDAQ:NUTX) Stock Price Up 8.3% – Should You Buy?

Nutex Health Inc. (NASDAQ:NUTX) was up 8.3% during mid-day trading on Wednesday . The stock traded as high as $109.00 and last traded at $109.7950. Approximately 78,077 shares were traded during trading, a decline of 60% from the average daily volume of 195,283 shares. The stock had previously closed at $101.38.

Analyst Ratings Changes

NUTX has been the topic of several recent research reports. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Nutex Health Stock Down 5.1%

The stock has a market capitalization of $704.95 million, a price-to-earnings ratio of 5.39 and a beta of -0.01. The business has a fifty day moving average of $157.26 and a 200 day moving average of $123.11. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18.

Nutex Health (NASDAQ:NUTX) last posted its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, topping the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The company had revenue of $243.99 million during the quarter, compared to analysts’ expectations of $221.93 million.

Insider Buying and Selling

In related news, CFO Jon Christian Bates bought 750 shares of the stock in a transaction on Tuesday, November 25th. The stock was bought at an average price of $136.71 per share, with a total value of $102,532.50. Following the completion of the purchase, the chief financial officer directly owned 5,638 shares in the company, valued at $770,770.98. This represents a 15.34% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 36.92% of the stock is owned by insiders.

Institutional Trading of Nutex Health

A number of institutional investors and hedge funds have recently bought and sold shares of NUTX. Topline Capital Management LLC boosted its stake in shares of Nutex Health by 80.0% in the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after purchasing an additional 247,436 shares during the period. Pertento Partners LLP acquired a new stake in Nutex Health during the 3rd quarter worth approximately $27,940,000. Vanguard Group Inc. boosted its position in Nutex Health by 12.7% in the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock valued at $22,209,000 after buying an additional 24,275 shares during the period. American Century Companies Inc. grew its stake in shares of Nutex Health by 39.9% in the second quarter. American Century Companies Inc. now owns 104,063 shares of the company’s stock worth $12,955,000 after acquiring an additional 29,704 shares in the last quarter. Finally, Marshall Wace LLP grew its stake in shares of Nutex Health by 333.4% in the second quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock worth $11,770,000 after acquiring an additional 72,734 shares in the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.